Correlation Between Neurocrine Biosciences and NESNVX

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and NESNVX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and NESNVX into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and NESNVX 47 15 JAN 53, you can compare the effects of market volatilities on Neurocrine Biosciences and NESNVX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of NESNVX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and NESNVX.

Diversification Opportunities for Neurocrine Biosciences and NESNVX

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Neurocrine and NESNVX is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and NESNVX 47 15 JAN 53 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NESNVX 47 15 and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with NESNVX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NESNVX 47 15 has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and NESNVX go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and NESNVX

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 3.56 times less return on investment than NESNVX. In addition to that, Neurocrine Biosciences is 1.23 times more volatile than NESNVX 47 15 JAN 53. It trades about 0.02 of its total potential returns per unit of risk. NESNVX 47 15 JAN 53 is currently generating about 0.08 per unit of volatility. If you would invest  9,143  in NESNVX 47 15 JAN 53 on September 25, 2024 and sell it today you would earn a total of  1,036  from holding NESNVX 47 15 JAN 53 or generate 11.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy61.11%
ValuesDaily Returns

Neurocrine Biosciences  vs.  NESNVX 47 15 JAN 53

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
NESNVX 47 15 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in NESNVX 47 15 JAN 53 are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, NESNVX may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Neurocrine Biosciences and NESNVX Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and NESNVX

The main advantage of trading using opposite Neurocrine Biosciences and NESNVX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, NESNVX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NESNVX will offset losses from the drop in NESNVX's long position.
The idea behind Neurocrine Biosciences and NESNVX 47 15 JAN 53 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges